{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:20Z","timestamp":1786991240539,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jacig.2024.100233","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T02:16:00Z","timestamp":1709172960000},"page":"100233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ustekinumab for pyoderma gangrenosum\u2013like skin ulcerations in late-onset leukocyte adhesion deficiency"],"prefix":"10.1016","volume":"3","author":[{"given":"Florian","family":"Schmid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Kerl-French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Meier-Schiesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lehmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3268-7479","authenticated-orcid":false,"given":"Peter H.","family":"Hoeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2024.100233_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hoc.2012.10.001","article-title":"Leukocyte adhesion deficiencies","volume":"27","author":"van de Vijver","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jacig.2024.100233_bib2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s13555-021-00507-x","article-title":"Pyoderma gangrenosum with an underlying leukocyte adhesion deficiency type 1 (LAD-1) and pregnancy in the shade of COVID-19 epidemic: a patient and physician experience","volume":"11","author":"Opali\u0144ska","year":"2021","journal-title":"Dermatol Therapy (Heidelb)"},{"key":"10.1016\/j.jacig.2024.100233_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.612703","article-title":"Clinical and genetic spectrum of a large cohort of patients with leukocyte adhesion deficiency type 1 and 3: a multicentric study from India","volume":"11","author":"Kambli","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2024.100233_bib4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood-2006-08-039057","article-title":"Somatic revertant mosaicism in a patient with leukocyte adheson deficiency type 1","volume":"109","author":"Tone","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jacig.2024.100233_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1525-1470.2010.01123.x","article-title":"Pyoderma gangrenosum-like lesions in leukocyte adhesion deficiency I treated with intravenous immunoglobulin","volume":"28","author":"Nord","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jacig.2024.100233_bib6","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJMoa1612197","article-title":"Interleukin-12 and interleukin-23 blockade in leukocyte adhesion deficiency type 1","volume":"376","author":"Moutsopoulos","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2024.100233_bib7","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1093\/bjd\/ljad259.009","article-title":"Long-term safety of ustekinumab in paediatric patients with moderate-to-severe plaque psoriasis: results from an ongoing observational study","volume":"189","author":"Mah\u00e9","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacig.2024.100233_bib8","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/GOX.0000000000001886","article-title":"Pyoderma gangrenosum-like wounds in leukocyte adhesion deficiency: case report and review of literature","volume":"6","author":"Simpson","year":"2018","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1016\/j.jacig.2024.100233_bib9","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1046\/j.1365-2133.1998.02567.x","article-title":"Pyoderma gangrenosum in a child with congenital partial deficiency of leucocyte adherence glycoproteins","volume":"139","author":"Bedlow","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacig.2024.100233_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10875-015-0155-3","article-title":"Leukocyte adhesion deficiency-i with a novel intronic mutation presenting with pyoderma gangrenosum-like Lesions","volume":"35","author":"Madkaikar","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100233_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2340\/00015555-1929","article-title":"Recurrent pyoderma gangrenosum and cystic acne associated with leucocyte adhesion deficiency due to novel mutations in ITGB2: successful treatment with infliximab and adalimumab","volume":"95","author":"Vahlquist","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jacig.2024.100233_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/0019-5154.108076","article-title":"Leukocyte adhesion defect type 1 presenting with recurrent pyoderma gangrenosum","volume":"58","author":"Thakur","year":"2013","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jacig.2024.100233_bib13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1525-1470.2010.01260.x","article-title":"Leukocyte adhesion deficiency type 1 presenting with recurrent pyoderma gangrenosum and flaccid scarring","volume":"27","author":"Hinze","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jacig.2024.100233_bib14","first-page":"119","article-title":"Pyoderma gangrenosum after bone marrow transplantation for leukocyte adhesion deficiency type 1","volume":"12","author":"Elenberg","year":"2010","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jacig.2024.100233_bib15","article-title":"Novel ITGB2 mutation is responsible for a severe form of leucocyte adhesion deficiency type 1","volume":"3","author":"Bouhouche","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jacig.2024.100233_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1182\/blood-2007-04-082552","article-title":"Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1)","volume":"111","author":"Uzel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jacig.2024.100233_bib17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jid.2021.08.431","article-title":"Molecular and cellular characterization of pyoderma gangrenosum: implications for the use of gene expression","volume":"142","author":"Ortega-Loayza","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jacig.2024.100233_bib18","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/bjd.15226","article-title":"Autoinflammation in pyoderma gangrenosum and ist syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)","volume":"176","author":"Marzano","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacig.2024.100233_bib19","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3389\/fimmu.2017.01980","article-title":"Classic ulcerative pyoderma gangrenosum is a t cell-mediated disease targeting follicular adnexal structures: a hypothesis based on molecular and clinicopathologic Studies","volume":"8","author":"Wang","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2024.100233_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.0906-6705.2003.00088.x","article-title":"Increased E-selectin, IL-8 and IL-10 gene expression in human skin after minimal trauma","volume":"12","author":"Takeuchi","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jacig.2024.100233_bib21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacig.2024.100233_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2005.01.011","article-title":"Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17","volume":"22","author":"Stark","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jacig.2024.100233_bib23","first-page":"262","article-title":"Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III","volume":"5","author":"Bakhtiar","year":"2021","journal-title":"Blood Advances"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T02:56:11Z","timestamp":1714964171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829324000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2772829324000298"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100233","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ustekinumab for pyoderma gangrenosum\u2013like skin ulcerations in late-onset leukocyte adhesion deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100233"}}